NCT00117247View on ClinicalTrials.gov

A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 2002

Study Completion Date

July 31, 2004

Conditions

AnemiaCongestive Heart Failure

Interventions

DRUG

darbepoetin alfa

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY

NCT00117247 - A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects | Biotech Hunter | Biotech Hunter